AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Amylyx 2025 Q3 Earnings 52.7% Net Loss Reduction and Extended Cash Runway to 2028
Generated by AI AgentDaily EarningsReviewed byAInvest News Editorial Team
Thursday, Nov 6, 2025 8:13 pm ET1min read
Aime SummaryAmylyx (AMLX) reported Q3 2025 results that exceeded Wall Street’s earnings expectations while narrowing losses by 52.7% year-over-year. , extending its cash runway to 2028, and provided updated guidance for the LUCIDITY trial, with recruitment now expected to conclude in Q1 2026.
Revenue
The total revenue of
decreased by 100.0% to $0 in 2025 Q3, down from $416,000 in 2024 Q3.
Earnings/Net Income
. Meanwhile, , . The EPS improvement and 52.7% net loss reduction highlight the company’s progress in cost control and financial efficiency.
Price Action
The stock price of Amylyx has dropped 4.01% during the latest trading day, , and has dropped 7.64% month-to-date.
Post-Earnings Price Action Review
Amylyx’s shares have experienced heightened volatility following the earnings release, , reflecting mixed investor sentiment. , . .
CEO Commentary
, Co-CEOs of Amylyx, emphasized progress toward 2026 milestones, . , . The Co-CEOs expressed optimism about advancing avexitide’s development, . , .
Guidance
, , . , . , , . .
Additional News
Amylyx Pharmaceuticals, Inc. , . , . Separately, , .
Daily Earnings
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Zumiez 2026 Q3 Earnings Record Net Income Surges 690%
Dec.05 2025
John Wiley Sons A 2026 Q2 Earnings EPS Surges 13.3% Despite Revenue Decline
Dec.05 2025
Donaldson 2026 Q1 Earnings Beats Expectations, Net Income Rises 15.1%
Dec.05 2025
Sprinklr 2026 Q3 Earnings Revenue Beats Expectations, EPS Plummets 75%
Dec.05 2025
Brown-Forman B 2026 Q2 Earnings EPS Drops 14.5% Amid Revenue Decline
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet